# Corpay, Inc.: overview

CPAY · NYSE · CIK 1175454 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpay.md) · [Financials](/companies/cpay/financials.md) · [Filings](/companies/cpay/filings.md) · [Insiders](/companies/cpay/insiders.md)

Latest reported revenue: [$1.34bn](/filings/0001175454-26-000050.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001175454-26-000050).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,029](/filings/0001175454-25-000029.md) | [1,034 d](/filings/0001175454-26-000018.md) | [1,006](/filings/0001175454-26-000032.md) | [1,102](/filings/0001175454-26-000050.md) | [1,172](/filings/0001175454-25-000029.md) | [1,248 d](/filings/0001175454-26-000018.md) | [1,261](/filings/0001175454-26-000032.md) | [1,339](/filings/0001175454-26-000050.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [45.5%](/filings/0001175454-25-000029.md) | [47.2% d](/filings/0001175454-26-000018.md) | [42.5%](/filings/0001175454-26-000032.md) | [43.5%](/filings/0001175454-26-000050.md) | [44.6%](/filings/0001175454-25-000029.md) | [45.2% d](/filings/0001175454-26-000018.md) | [50.4%](/filings/0001175454-26-000032.md) | [35.3%](/filings/0001175454-26-000050.md) |
| Net margin | % | [26.9%](/filings/0001175454-25-000029.md) | [23.8% d](/filings/0001175454-26-000018.md) | [24.2%](/filings/0001175454-26-000032.md) | [25.8%](/filings/0001175454-26-000050.md) | [23.7%](/filings/0001175454-25-000029.md) | [21.2% d](/filings/0001175454-26-000018.md) | [27.8%](/filings/0001175454-26-000032.md) | [18.5%](/filings/0001175454-26-000050.md) |
| Diluted EPS | $ per share | [3.90](/filings/0001175454-25-000029.md) | not reported | [3.40](/filings/0001175454-26-000032.md) | [3.98](/filings/0001175454-26-000050.md) | [3.91](/filings/0001175454-25-000029.md) | not reported | [5.07](/filings/0001175454-26-000032.md) | [3.70](/filings/0001175454-26-000050.md) |
| Free cash flow | $m | [355 d](/filings/0001175454-25-000029.md) | [605 d](/filings/0001175454-26-000018.md) | [(119)](/filings/0001175454-26-000032.md) | [1,088 d](/filings/0001175454-26-000050.md) | [(430) d](/filings/0001175454-25-000029.md) | [760 d](/filings/0001175454-26-000018.md) | [(108)](/filings/0001175454-26-000032.md) | [1,416 d](/filings/0001175454-26-000050.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,834](/filings/0001628280-24-008060.md) | [3,427](/filings/0001628280-25-008746.md) | [3,758](/filings/0001175454-26-000018.md) | [3,975](/filings/0001175454-26-000018.md) | [4,528](/filings/0001175454-26-000018.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [43.8%](/filings/0001628280-24-008060.md) | [42.2%](/filings/0001628280-25-008746.md) | [44.1%](/filings/0001175454-26-000018.md) | [45.0%](/filings/0001175454-26-000018.md) | [44.0%](/filings/0001175454-26-000018.md) |
| Net margin | % | [29.6%](/filings/0001628280-24-008060.md) | [27.8%](/filings/0001628280-25-008746.md) | [26.1%](/filings/0001175454-26-000018.md) | [25.3%](/filings/0001175454-26-000018.md) | [23.6%](/filings/0001175454-26-000018.md) |
| Diluted EPS | $ per share | [9.99](/filings/0001628280-24-008060.md) | [12.42](/filings/0001628280-25-008746.md) | [13.20](/filings/0001175454-26-000018.md) | [13.97](/filings/0001175454-26-000018.md) | [15.03](/filings/0001175454-26-000018.md) |
| Free cash flow | $m | [1,086](/filings/0001628280-24-008060.md) | [603](/filings/0001628280-25-008746.md) | [1,947](/filings/0001175454-26-000018.md) | [1,765](/filings/0001175454-26-000018.md) | [1,299](/filings/0001175454-26-000018.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cpay/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.90bn | 5,709,856 |  | Reduced −463,642 |
| [Orbis Allan Gray Ltd](/funds/1663865.md) | 2026-06-30 | $1.80bn | 5,408,507 |  | Added +63,082 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.60bn | 4,766,416 |  | Reduced −55,024 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.39bn | 4,162,643 |  | Reduced −264,819 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.11bn | 3,344,049 |  | Added +647,123 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $943.7m | 2,831,554 |  | Reduced −111,069 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $939.3m | 2,811,551 |  | Added +390,774 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $925.4m | 2,776,845 |  | Reduced −215,046 |
| [TIGER GLOBAL MANAGEMENT LLC](/funds/1167483.md) | 2026-06-30 | $716.5m | 2,149,877 |  | Added +397,731 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $605.8m | 1,775,827 |  | Reduced −170,215 |

## Recent filings

[All 1,451 filings](/companies/cpay/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 21:39 ET | [10-Q](/filings/0001175454-26-000050.md) | Quarterly report, period 2026-06-30 | 0001175454-26-000050 |
| 2026-08-05 | 20:13 ET | [8-K](/filings/0001175454-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175454-26-000045 |
| 2026-07-24 | 20:58 ET | [8-K](/filings/0001175454-26-000042.md) | 5.02 Departure or appointment of officers or directors | 0001175454-26-000042 |
| 2026-05-22 | 20:15 ET | [8-K](/filings/0001175454-26-000040.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175454-26-000040 |
| 2026-05-12 | 21:01 ET | [8-K](/filings/0001175454-26-000036.md) | 7.01 Regulation FD disclosure | 0001175454-26-000036 |
| 2026-05-12 | 20:15 ET | [8-K](/filings/0001175454-26-000034.md) | 5.07 Shareholder vote results | 0001175454-26-000034 |
| 2026-05-08 | 12:41 ET | [10-Q](/filings/0001175454-26-000032.md) | Quarterly report, period 2026-03-31 | 0001175454-26-000032 |
| 2026-05-07 | 20:14 ET | [8-K](/filings/0001175454-26-000029.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175454-26-000029 |
| 2026-04-27 | 12:33 ET | [8-K](/filings/0001175454-26-000027.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001175454-26-000027 |
| 2026-04-10 | 20:21 ET | [DEF 14A](/filings/0001175454-26-000022.md) | Proxy statement, period 2025-12-31 | 0001175454-26-000022 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001175454-26-000018.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8969117b-9bbb-495c-9a60-bd9073a54086)

## About the filer

- CIK: 1175454
- Tickers: CPAY
- Exchange: NYSE
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.